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background: Labor is considered to be one of the most painful experiences in life. Several efforts have been made over 
the years, particularly in the developed world, to relieve pain in labor. Unfortunately, the same attention has not been given 
to obstetric analgesia in most of Africa.
Aim: To compare the analgesic efficacy, patient satisfaction, and side effects of intramuscular tramadol and paracetamol 
as pain relief among women in labor at University College Hospital (UCH), Ibadan, Nigeria.
Materials and Methods: This was a prospective double‑blind randomized controlled trial that recruited 142 parturients into two 
groups of 71 women. One group received intramuscular 600 mg paracetamol and the other 100 mg tramadol at recruitment 
with rescue dose at least 3 h apart. Maternal vital signs were monitored and labor pain was assessed using the numerical 
rating scale. Neonatal conditions were assessed by the use of APGAR scoring system and the need for admission into the 
Special Care Baby Unit. The parturients overall satisfaction with the analgesia were assessed 24 h postpartum.
Results: The sociodemographic characteristics of the pregnant women in the two groups were similar, with the mean ages 
being 30.89 ± 3.50 and 30.93 ± 3.82 years, respectively. The study showed that intramuscular paracetamol was as effective 
as intramuscular tramadol for providing moderate pain relief during active phase of labor. Neither drug caused significant 
changes in maternal vital signs, with favorable neonatal outcome and good safety profile.
Conclusions: This study showed that 600 mg intramuscular paracetamol provides similar and modest pain relief in labor 
when compared to 100 mg intramuscular tramadol. It also has fewer maternal adverse effects and favorable neonatal outcome 
such as tramadol. It is concluded that intramuscular paracetamol is simple, cost‑effective, readily available, and feasible 
option as labor analgesics, especially for resource poor settings.
Key words: Labor; numerical rating scale; pain; paracetamol; tramadol.
Introduction
Labor is a painful process and may be the most painful 
experience many women ever encounter.[1] The experience is 
different for each woman, and the different methods chosen 
to relieve pain depend upon the techniques available locally 
and the personal choice of the individual patient or health 
workers. Pain during labor is a physiological phenomenon. The 
evolution of pain during first stage of labor is associated with 
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ischemia of the uterus during contraction as well as effacement 
and dilation of cervix.[2] In the second stage, pain is caused by 
stretching of the vagina, perineum, and compression of pelvic 
structures. However, pain sensation is a response of the total 
personality and is a subjective phenomenon.
There is no circumstance in which it is considered acceptable 
for a person to experience severe pain especially while 
under a physician’s care.[3] The importance of analgesia as a 
contribution to overall satisfaction of pain management has 
been recognized increasingly in the last 50 years.[4]
Labor is generally considered to be a painful experience, 
and effective pain relief in labor by the use of appropriate 
analgesic agent is important and helpful at ameliorating the 
unpleasant effects of unrelieved labor pain, which include 
psychological disturbance, anxiety, mood depression, delayed 
bonding, and possible animosity to the care giver.
Epidural analgesia is the most effective analgesia for women 
in labor.[5] Unfortunately, epidural services are not routinely 
available in most obstetric units in developing countries for 
reasons of cost and personnel. Most labor suites, therefore, 
use systemic opioids for analgesia. These are cheap, simple 
to use, and readily available. Since its introduction in 1939, 
pethidine has become the most commonly used opioid for 
obstetric analgesia throughout the world despite unimpressive 
safety records,[6,7] which include nausea, vomiting, sedation, 
respiratory depression, and delayed gastric emptying.[5,8,9]
Tramadol is a synthetic analog of codeine that binds µ-opiate 
receptors and inhibits norepinephrine and serotonine 
uptake.[10] Studies by Tarkilla et al. and Murphy et al. showed 
that tramadol is an effective analgesic without the maternal 
and neonatal respiratory depression common to other 
opioids and it does not delay gastric emptying.[11,12]
Paracetamol (acetaminophen) is one of the world’s most 
widely used analgesics.[13] It has a central analgesic effect 
that is mediated through activation of the descending 
serotonergic pathways. Studies have shown that effectiveness 
of intravenous paracetamol was comparable to that of 
intravenous pethidine, with none of the women in the 
paracetamol group having adverse effects, as compared 
with 64% of the women receiving pethidine.[14] Another 
similar study comparing the effectiveness of paracetamol 
to pethidine in labor conducted in Iran concluded that 
intravenous paracetamol is more effective than intramuscular 
pethidine to relieve labor pain in normal vaginal delivery.[15] 
These two studies show the effectiveness and safety of 
paracetamol as labor analgesia.
Paracetamol (acetaminophen) is a safe and effective 
agent for pain management. Studies have suggested that 
paracetamol is an effective treatment for postoperative pain 
relief.[16,17] Studies examining analgesic effect of paracetamol 
in obstetrics surgeries such as abortion,[18] postoperative 
pain after cesarean delivery,[19,20] and perineal pain after child 
birth[21,22] have proposed that paracetamol has an admirable 
analgesic effect; however, there are limited clinical trials 
regarding paracetamol analgesic effect on labor pain. The 
available studies report similar efficacy between paracetamol 
and pethidine in labor without the associated feto-maternal 
effects of pethidine.[14,15] Studies on tramadol, an opioid 
analgesic, also reported less maternal sedative effect and less 
neonatal respiratory depression compared to pethidine.[23] 
Supporting this, a study by Veigas et al. in 1993,[24] who opined 
that tramadol 100 mg is as effective as pethidine 75 mg, but 
has a superior safety profile. The present study is, therefore, 
aimed at comparing the efficacy of intramuscular paracetamol 
with intramuscular tramadol in labor.
Materials and Methods
It was a prospective double-blind randomized controlled 
trial (RCT) conducted at the labor ward complex of the 
University College Hospital (UCH), Ibadan, Oyo State, Nigeria 
between the 14 April and 4 December, 2015 among the 
women in established labor and met the inclusion criteria. 
One hundred and forty-two (142) consenting pregnant 
women were recruited after informed consent.
This double-blind RCT compared 100 mg intramuscular 
tramadol and 600 mg intramuscular paracetamol in active phase 
of labor. Information about the trial drugs was provided to the 
women and they were also educated on pain assessment using 
numerical rating scale (NRS). The participants were made to 
understand that their participation was voluntary and that they 
had the freedom and liberty to withdraw from participating at 
any stage of the study and their decision would not by any way 
negatively or positively influence their subsequent care from 
the medical personnel. Consented women were recruited for 
the trial when in active phase of labor.
The study employed block randomization in group of 8. The 
sequence of randomization was generated using a computer 
program ensuring equal numbers of the prepared trial drugs. 
Due to the differences in the shape and the volume of 100 mg 
tramadol (2 ml) and 600 mg paracetamol (4 ml), reconstitution 
was done and coded by the hospital Pharmacist under aseptic 
conditions using sterile water to 5 ml in a syringe on a rolling 
basis (fresh batches were prepared as additional participants 
were enrolled). Both liquids were colorless, so the syringes 
containing the two drugs were indistinguishable.
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The UCH Pharmacist, who had the randomization sequence, 
prepared the trial drugs into sequentially numbered 
envelopes in groups of 8 at a time. Each group contained 
four set of envelopes containing three prepared trial drugs 
each, to ensure that if two or more doses were given, the 
same drug was given both times.
The envelopes were labeled with trial numbers only known 
to the Pharmacist in order to conceal group allocation from 
the midwife, the parturients, and the researcher.
Randomization codes were placed in sequentially numbered, 
opaque, sealed envelope. When each woman requested for 
pain relief, the next numbered envelope was opened and 
the appropriate drug was administered by the randomizing 
resident or researchers. Once recruited, women were 
randomly allocated to receive either intramuscular 
paracetamol 600 mg or tramadol 100 mg slowly into the 
gluteus muscle or muscles of the lateral thigh.
Protocol
One hundred and seven (75.4%) participants received a single 
dose of the trial drugs, with 35 (24.6%) receiving two doses 
of trial drugs at a minimum interval of 3 h following request 
for rescue dose. Their pain score and maternal vital signs 
were assessed at intervals using NRS for the pain assessment 
till delivery and fetal outcome was assessed using APGAR 
scoring system and the need for admission to Special Care 
Baby Unit (SCBU).
This study aimed to use safe analgesia in active phase of 
labor at intervals, to alleviate or reduce labor pain to the 
barest minimum.
Assessment of outcome
Researchers and/or labor ward resident doctors, unaware of 
the type of injection given, recorded the clinical data and 
assessed the analgesic efficacy.
Maternal vital signs (pulse, blood pressure, respiratory rate) 
and labor pain were assessed immediately before giving the 
drug at 30, 60 min, then hourly after injection of the trial 
drug, till next request for analgesia or delivery.
Assessment of labor pain and pain relief was also assessed 
using a NRS.
The incidence of maternal vomiting, nausea, sedation, as well 
as any other side effects were noted. Maternal sedation was 
assessed on a three-point scale as: 0 = Alert, 1 = Drowsy, 
2 = Asleep.
The request for rescue analgesia and the time interval after 
the recruitment dose was noted. Intrapartum monitoring 
was ensured according to our usual standard labor ward 
protocol. The time, duration of active phase of labor, and type 
of delivery were noted. Neonatal condition was assessed by 
the use of APGAR scoring system and the need for admission 
to SCBU.
The parturients overall satisfaction with the analgesia was 
also assessed 24 h postpartum.
Data analysis
Data obtained were coded and entered into a computer 
running Statistical Package for the Social Sciences, 
version 21 for Windows (SPSS-21). Initial analysis was done 
by generation of frequency tables, while further analyses 
were performed by cross-tabulations to explore statistical 
relationship between variables in the two groups. The 
differences between the tramadol and paracetamol groups 
were assessed using the nonparametric test, i.e., Chi-square 
test for categorical variables. The mean and standard 
deviation of normally distributed continuous variables 
were compared using the independent t-test. Variables not 
normally distributed were measured using Fisher’s exact 
test. Numerical values were in means ± standard deviations 
and 95% confidence interval (CI) was calculated. Differences 
between the two parameters were taken as statistically 
significant when P values were <0.05.
Results
Two hundred women in labor were assessed for eligibility, 
out of which 160 women met the eligibility criteria 
for the study; however, only 142 consented and were 
randomized.
Sociodemographic characteristics of respondents
The sociodemographic characteristics of the women in 
tramadol group and paracetamol group are presented 
in Table 1. Patients <30 years old were 30 (42.3%) in 
paracetamol group and 37 (52.1%) in tramadol group with 
patients >35 years being 41 (57.7%) in paracetamol and 
34 (47.9%) in tramadol group.
The mean ages for the subjects in the paracetamol group were 
30.89 ± 3.50 years, and 30.93 ± 3.82 years in the tramadol 
group, with the age ranging from 19 to 39 years.
The results, however, showed that there was no 
significant differences in all the sociodemographic 
characteristics (P > 0.05) in the subjects (paracetamol group 
and tramadol group).
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postpartum. However, at 120 min, 180 min postrescue 
dose, and 60 min postpartum, an obvious increase was 
observed in the mean pain scores of those in paracetamol 
group. Although, this difference was not statistically 
significant (P values = 0.36, 0.06, and 0.10, respectively).
The mean maternal vital signs scores in paracetamol 
and tramadol groups at various time intervals
Table 3 shows the maternal vital signs scores in paracetamol 
and tramadol groups at various time intervals. Following the 
administration of recruitment dose, there was no significant 
difference in the mean respiratory rate, pulse rate, systolic 
blood pressure, and diastolic blood pressure scores in 
both groups at recruitment, 30, 60, 120, 180 min, 60 min 
postpartum, and 120 min postpartum (P > 0.05).
After the administration of first rescue dose, there was no 
significant difference in the mean respiratory rate, pulse rate, 
systolic blood pressure, and diastolic blood pressure scores in 
both groups at recruitment, 30, 60, 120, 180 min, 60 minutes 
postpartum, and 120 minutes postpartum (P > 0.05).
Labor history of the parturients
Table 4 shows that there was no significant difference in 
those who had their labor augmented between paracetamol 
group and tramadol group (P = 0.10). Similarly, proportion 
of those who had prior analgesic was similar in both 
paracetamol and tramadol groups ( 2 = 0.18, P = 0.67). 
Among 28 (19.7%) women who had prior analgesic, 27 (96.4%) 
had 30 mg intramuscular pentazocine while only 1 (3.6%) 
had 600 mg intramuscular paracetamol. Fourteen (93.3%) 
women in paracetamol group had pentazocine, while 
13 (100.0) were in tramadol group. This difference was also 
not significant. ( 2 = 0.90, P = 0.634).
Duration of labor and cervical dilatation
Table 5 shows mean duration of labor at various cervical 
dilatations between paracetamol and tramadol groups. There 
was no statistically significant difference in mean duration 
of labor between paracetamol group and tramadol group 
at 4, 5, 6, and 7 cm cervical dilatations. Also, the mean 
drug-to-delivery interval was shorter in the paracetamol 
group as compared to the tramadol group (297 ± 200 
vs 307 ± 224 min, P = 0.73) but the difference was not 
statistically significant.
Maternal side effects of the trial drugs
Equal proportion of women with nausea were found in 
paracetamol group [2 (50%)] and tramadol group [2 (22.2%)], 
as shown in Table 6. However, vomiting was more in tramadol 
group [7 (77.8%)] compared to [2 (50%)] paracetamol group. 
Those found to be drowsy were one in each group. None 
Severity of pain in paracetamol and tramadol groups at 
various time intervals
Table 2 shows the mean pain score in paracetamol and tramadol 
groups at various time intervals. Following the administration 
of recruitment dose, there was no significant difference in the 
mean pain score in both groups at recruitment, 30, 60, 120, 
180 min, 60 min postpartum, and 120 min postpartum.
Thirty five (24.6%) of all the participants (142) had a rescue 
dose of the trial drugs. Out of this, 18 (51.4%) were in 
the paracetamol group and 17 (48.6%) in the tramadol 
groups. Although, these differences were not statistically 
significant ( 2 = 0.04, P value = 0.85).
After the administration of first rescue dose, there was no 
significant difference in the mean pain score in both groups 
at recruitment, 30 min, 60 min postrescue dose, and 120 min 
Table 1: Sociodemographic characteristics of respondents
Variables Paracetamol (%) Tramadol (%) Chi‑square P
Age (years)
≤30 30 (42.3) 37 (52.1) 1.39 0.24





13 (18.3) 6 (8.5) 2.98 0.08
Tertiary 58 (81.7) 65 (91.5)
Tribe
Yoruba 58 (81.7) 62 (87.3) 1.49 0.48
Igbo/Hausa 13 (18.3) 9 (12.7)
Booking status
Booked 57 (80.3) 59 (83.1) 0.19 0.66
Unbooked 14 (19.7) 12 (16.9)







Recruitment dose (N: 142)
At recruitment (0 min) 7.97±1.46 7.89±1.45 0.35 0.73
30 min 6.76±1.57 6.93±1.51 –0.65 0.51
60 min 6.51±1.54 6.59±1.52 −0.33 0.74
120 min 6.70±1.31 6.52±1.46 0.75 0.45
180 min 6.98±1.50 6.79±1.56 0.64 0.52
60 min postpartum 1.23±1.43 1.00±1.27 0.83 0.41
120 min postpartum 0.63±1.18 0.58±1.07 0.18 0.86
First rescue dose (N: 35) N: 18 N: 17
At recruitment (0 min) 8.56±1.15 8.56±1.10 0.00 1.00
30 min 6.89±1.45 7.44±1.38 −1.18 0.25
60 min 7.07±1.27 6.59±1.12 1.13 0.28
120 min 7.25±1.28 6.67±1.44 0.93 0.36
180 min 8.00±1.63 6.25±1.17 2.16 0.06
60 min postpartum 0.70±0.83 1.62±1.81 −1.65 0.10
120 min postpartum 0.07±0.27 0.69±1.11 −1.97 0.05
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was found to be sleepy in either of the two trial drugs. The 
results show that there is no significant difference in maternal 
side effects between paracetamol and tramadol ( 2 = 2.96, 
P value 0.09).
Patient satisfaction with trial drug 24 h post delivery
Table 7 shows that out of the 142 participants, only 32 (22.5%) 
expressed their dissatisfaction to the trial drug, out of which 
18 (25.4%) were in tramadol group as against 14 (19.7%) in 
paracetamol group. About half of the respondents, 65 (45.8%) 
were satisfied out of which 35 (49.3%) were in paracetamol group 
and 30 (42.3%) were in tramadol group. Forty-five parturients 
were slightly satisfied with trial drug; 22 (31.0%) were in 
paracetamol group while 23 (32.4%) were in tramadol group.
The difference in satisfaction between the two trial drugs 
was, however, not significant ( 2 = 0.91, P value = 0.64).
Mode of delivery of the patients
Table 8 shows mode of delivery of the patients. Equal 
proportion, 58 (81.7%), of women had vaginal delivery in both 
groups. One of the women in tramadol group had instrumental 
vaginal delivery. Similarly, equal proportion of 18.3% of the 
women in tramadol and paracetamol groups had emergency 
cesarean section (CS) with only one participant in paracetamol 
group having emergency CS as a result of fetal distress.
The results showed that there was no significant difference in 
the mode of delivery of patients in paracetamol and tramadol 
groups ( 2 = 0.00, P value = 1.0).
Table 3: Mean maternal vital signs in paracetamol and tramadol 






At recruitment 0 min, N=142
RR/min 23.68±2.31 23.72±2.33 −0.11 0.91
PR/min 85.94±10.26 84.70±12.30 0.65 0.52
BP systolic 117.89±12.97 115.49±11.44 1.17 0.25
BP diastolic 73.80±9.62 74.37±9.82 −0.35 0.73
30 min
RR/min 23.51±1.94 23.38±2.02 0.38 0.70
PR/min 86.31±6.84 85.18±5.88 1.05 0.29
BP systolic 116.62±10.27 116.90±9.80 −0.17 0.87
BP diastolic 73.38±8.10 73.80±7.24 −0.33 0.74
60 min
RR/min 23.76±3.14 23.92±2.25 0.34 0.74
PR/min 86.89±6.77 85.83±7.72 0.87 0.39
BP systolic 118.03±10.77 119.01±10.84 −0.54 0.59
BP diastolic 74.51±7.71 74.92±8.62 −0.30 0.77
120 min, N=136
RR/min 23.67±1.93 23.57±1.84 0.33 0.74
PR/min 85.64±7.55 86.29±12.71 −0.36 0.72
BP systolic 117.61±10.46 117.17±10.62 0.24 0.81
BP diastolic 74.18±8.19 75.29±10.21 −0.70 0.49
180 min, N=107
RR/min 23.22±2.18 24.23±2.65 −2.14 0.03
PR/min 86.85±9.21 85.81±7.82 0.63 0.53
BP systolic 118.52±11.88 120.57±11.67 −0.90 0.37
BP diastolic 74.26±5.70 77.55±9.98 −2.10 0.04
First rescue dose 0 min N=35
RR/min 23.18±2.46 24.11±2.32 −1.16 0.26
PR/min 82.12±20.09 89.00±6.30 −1.35 0.18
BP systolic 121.18±11.11 121.67±10.98 −0.13 0.90
BP diastolic 77.06±5.88 77.78±10.60 -0.25 0.81
30 min
RR/min 23.94±1.95 23.50±2.00 0.66 0.52
PR/min 83.88±5.02 86.33±7.86 −1.11 0.28
BP systolic 121.18±10.54 120.56±11.10 0.17 0.87
BP diastolic 74.12±7.12 77.78±8.78 −1.35 0.19
60 min, N=31
RR/min 24.00±1.57 24.24±1.72 −0.40 0.70
PR/min 85.43±6.20 85.65±6.68 −0.09 0.93
BP systolic 117.86±8.93 119.61±9.72 −0.37 0.71
BP diastolic 72.14±4.26 75.29±11.25 −0.99 0.33
120 min, N=20
RR/min 23.50±2.07 24.33±1.87 −0.94 0.36
PR/min 83.00±6.41 86.33±7.48 −1.03 0.32
BP systolic 118.75±8.35 122.50±9.65 −0.89 0.38
BP diastolic 76.25±7.44 77.50±9.65 −0.31 0.76
180 min, N=10
RR/min 25.00±2.00 23.75±1.98 1.02 0.33
PR/min 81.00±10.00 84.25±11.08 −0.49 0.63
BP systolic 117.50±5.00 126.25±15.98 −1.05 0.32
BP diastolic 75.00±5.774 82.50±14.88 −0.95 0.36
60 min postpartum N=116







PR/min 85.69±7.42 86.60±7.98 −0.64 0.52
BP systolic 116.03±10.07 117.59±11.89 −0.76 0.45
BP diastolic 73.10±7.77 73.79±7.45 −0.49 0.63
120 min postpartum
RR/min 22.59±3.09 22.10±1.81 1.03 0.31
PR/min 84.28±6.68 84.55±7.86 −0.20 0.84
BP systolic 113.79±8.75 117.38±8.49 −2.24 0.03
BP diastolic 72.07±05.85 73.24±6.77 −0.10 0.32
Contd...
Table 4: Labor history of the parturients
Variables Paracetamol (%) Tramadol (%) Chi‑square P
Augmentation
Yes 36 (52.2) 37 (52.1) 73 (52.1) 0.10
No 33 (47.8) 34 (47.3) 67 (47.9)
Prior analgesic 
given
Yes 15 (21.1) 13 (18.3) 28 (19.7) 0.67
No 56 (78.9) 58 (81.7) 114 (80.3)
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Neonatal condition
As shown in Table 9, 4 (2.8%) babies were admitted to SCBU 
and these four were in tramadol group. The indications for 
admission were fetal macrosomia with perinatal asphyxia, 
small for gestational age, tachypnea of newborn, and 
moderate asphyxia following instrumental vaginal delivery.
Out of the 71 deliveries in each group, 60 (84.5%) neonates 
and 52 (73.2%) had APGAR score more than 7 in the 
paracetamol and tramadol groups at 1 min, which increased 
at 5 mins to 71 (100%) in paracetamol group and 70 (98.6%) 
in tramadol group of the neonates.
Discussion
Results of the current study have shown that the 
sociodemographic characteristics of pregnant women in 
paracetamol and tramadol groups were similar at baseline. 
Booked patients were more than unbooked patients in the 
study. These results are similar to the study conducted by 
Kaur Makkar et al.[25] (2015), where the researchers compared 
analgesic efficacy of paracetamol and tramadol for pain 
relief in active labor in India. Gestational age at labor was 
not significantly different in both paracetamol and tramadol 
groups.
The findings from the study showed that mean pain score 
reduced more in paracetamol group compared to tramadol 
group up till 60 minutes of drug administration although 
this was not significant. This was further reflected in slight 
reduction in mean duration of active labor in paracetamol 
group compared to tramadol group. Parturients in this 
study generally responded to both intramuscular analgesics 
almost the same way. In other words, it was shown in the 
study that the intramuscular paracetamol was as effective 
as intramuscular tramadol for providing pain relief during 
active labor. Analgesic effect of both drugs lasted for 2 hours 
as determined by the lower pain scores at recruitment, 30, 
60, 120 min from the baseline. This is also comparable with 
Table 5: Mean duration of labor and cervical dilatation (4‑7 cm)





Cervical dilation at 
recruitment (cm)






297±200 307±224 −0.34 0.73
Table 6: Maternal side effects of the trial drugs
Variable Type of analgesic P
Paracetamol (%) Tramadol (%)
Maternal side effect
Nausea 2 (50.0) 2 (22.2) *0.53
Vomiting 2 (50.0) 7 (77.8)
Sedation
Alert 70 (98.6) 70 (98.6) *1.00
Drowsy 1 (1.4) 1 (1.4)
*Fisher’s exact test statistics
Table 7: Patient satisfaction with trial drug 24 hours post 
delivery






Satisfied 35 (49.3) 30 (42.3) 0.91 0.64
Slightly 
satisfied
22 (31.0) 23 (32.4)
Dissatisfied 14 (19.7) 18 (25.4)







Vaginal delivery 58 (81.7) 58 (81.7) 0.00 1.0
Emergency 
cesarean
13 (18.3) 13 (18.3)






CPD related 11 (84.6%) 13 (100%) 3.39 0.18




Table 9: Neonatal condition







Yes 0 (0) 4 (5.6) - *0.12
No 71 (100) 67 (94.4)
Apgar score at 
1 min
≤7 11 (15.5) 19 (26.8) 2.03 0.15
>7 60 (84.5) 52 (73.2)
Apgar score at 
5 min
≤7 0 (0.0) 1 (1.4) - *1.00
>7 71 (100) 70 (98.6)
*Fisher’s exact test statistic
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findings from Kaur Makkar et al.,[25] where the researchers 
reported that analgesic effect of both tramadol and 
paracetamol showed lower pain scores at 10, 20, 30, 60, 
and 120 min.
In this study, the proportion of those who had augmentation 
of labor was comparable in both paracetamol and tramadol 
groups. Similarly, those who had prior analgesia were also 
comparable in both groups. It is noteworthy to report that 
the mean duration of labor of those who had prior analgesia 
was slightly higher than in those who did not receive prior 
analgesia. One explanation for this is that those who had 
prior analgesia combined with the trial analgesia experienced 
more effective labor analgesia.
A study by Arya et al.[5] reported that maternal side effects 
have been observed with tramadol, which include sedation, 
nausea, vomiting, orthostatic hypotension, and respiratory 
depression. This study showed that vomiting was observed 
more with patients in tramadol group but other reported 
side effects by Arya et al. were not noted in this study. Also in 
agreement to the study by Arya et al., 2003, results from the 
current study have also shown that more patients in Tramadol 
group experienced drowsiness. None of the mothers fell 
asleep after drug administration. Also, neither drugs caused 
significant changes in maternal blood pressure, pulse rate, 
and respiratory rate. Kuti et al.[26] similarly reported this 
finding in their study. The present study also showed that 
mothers were more satisfied with the use of paracetamol 
during labor. Both drugs, however, showed better safety 
profile with fewer incidences of vomiting and sedation. It 
can be adduced from this study that both trial drugs can be 
safely used in labor.
Furthermore, the mean drug-to-delivery interval was shorter 
with the use of paracetamol as compared to tramadol. 
These results are in accordance with Kaur Makkar et al.,[25] 
where mean drug-to-delivery was significantly shorter in 
paracetamol group, and the study of Elbohoty et al.,[14] where 
the researchers reported mean drug-to-delivery interval was 
shorter with the use of paracetamol as compared to pethidine. 
Various studies reported varied mean duration of labor of 
tramadol and paracetamol. Khooshideh and Shahriari[27] 
showed a significant shorter duration of labor with the use 
of tramadol. Whereas, a study by Keskin et al.[28] and Kuti et al. 
did not report any significant difference between pethidine 
and tramadol groups. Viegas et al.[24] reported in their study 
that mean duration of labor was similar between pethidine 
group and paracetamol group. In this study, there was a 
reduction in the duration of labor after administration of 
intramuscular paracetamol; hence total duration of labor was 
reduced in patients who received paracetamol as compared to 
tramadol. This could be due to the fact that tramadol causes 
sedation leading to lesser mobility of women in labor, which 
could lengthen the labor.
Equal proportion of women in paracetamol and tramadol 
groups had emergency CSs. Those who had spontaneous 
vaginal deliveries were also compaed between the two 
groups. This result is in accordance with the findings of 
Kaur Makkar et al. (2015), where there was no difference 
found in the incidence of cesarean deliveries with four 
patients undergoing operative delivery in paracetamol 
group as compared with four patients in tramadol group. 
Neonatal outcome was favorable with both paracetamol 
and tramadol.
Conclusion and Recommendation
The findings from the present study showed that 600 mg 
intramuscular paracetamol provided similar and modest pain 
relief in labor compared to 100 mg intramuscular tramadol. 
Paracetamol was noticed to have fewer maternal adverse 
effects than tramadol; also the neonatal outcomes of both the 
drugs were favorable. So from the study, it can be concluded 
that intramuscular paracetamol is simple, cost-effective, has 
fewer maternal side effects, readily available, and feasible 
option as labor analgesics, especially for resource poor 
settings.
It might be more appropriate if similar study could be 
repeated by working with the pharmaceutical companies to 
produce both drugs strength in the same volume to avoid 
re-constitution.
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